Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Correction for Sun et al., "Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models".

Sun X, Belser JA, Pappas C, Pulit-Penaloza JA, Brock N, Zeng H, Creager HM, Le S, Wilson M, Lewis A, Stark TJ, Shieh WJ, Barnes J, Tumpey TM, Maines TR.

J Virol. 2019 Jun 14;93(13). pii: e00476-19. doi: 10.1128/JVI.00476-19. Print 2019 Jul 1. No abstract available.

PMID:
31201279
2.

Swine-Origin H1 Influenza Viruses Isolated from Humans Exhibit Sustained Infectivity in an Aerosol State.

Pulit-Penaloza JA, Belser JA, Tumpey TM, Maines TR.

Appl Environ Microbiol. 2019 May 2;85(10). pii: e00210-19. doi: 10.1128/AEM.00210-19. Print 2019 May 15.

PMID:
30877121
3.

Sowing the Seeds of a Pandemic? Mammalian Pathogenicity and Transmissibility of H1 Variant Influenza Viruses from the Swine Reservoir.

Pulit-Penaloza JA, Belser JA, Tumpey TM, Maines TR.

Trop Med Infect Dis. 2019 Feb 27;4(1). pii: E41. doi: 10.3390/tropicalmed4010041. Review.

4.

Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.

Sun X, Belser JA, Pappas C, Pulit-Penaloza JA, Brock N, Zeng H, Creager HM, Le S, Wilson M, Lewis A, Stark TJ, Shieh WJ, Barnes J, Tumpey TM, Maines TR.

J Virol. 2018 Dec 10;93(1). pii: e01740-18. doi: 10.1128/JVI.01740-18. Print 2019 Jan 1. Erratum in: J Virol. 2019 Jun 14;93(13):.

5.

Comparative In Vitro and In Vivo Analysis of H1N1 and H1N2 Variant Influenza Viruses Isolated from Humans between 2011 and 2016.

Pulit-Penaloza JA, Pappas C, Belser JA, Sun X, Brock N, Zeng H, Tumpey TM, Maines TR.

J Virol. 2018 Oct 29;92(22). pii: e01444-18. doi: 10.1128/JVI.01444-18. Print 2018 Nov 15.

6.

Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.

Sun X, Pulit-Penaloza JA, Belser JA, Pappas C, Pearce MB, Brock N, Zeng H, Creager HM, Zanders N, Jang Y, Tumpey TM, Davis CT, Maines TR.

J Virol. 2018 Jul 31;92(16). pii: e00665-18. doi: 10.1128/JVI.00665-18. Print 2018 Aug 15.

7.

Antigenically Diverse Swine Origin H1N1 Variant Influenza Viruses Exhibit Differential Ferret Pathogenesis and Transmission Phenotypes.

Pulit-Penaloza JA, Jones J, Sun X, Jang Y, Thor S, Belser JA, Zanders N, Creager HM, Ridenour C, Wang L, Stark TJ, Garten R, Chen LM, Barnes J, Tumpey TM, Wentworth DE, Maines TR, Davis CT.

J Virol. 2018 May 14;92(11). pii: e00095-18. doi: 10.1128/JVI.00095-18. Print 2018 Jun 1.

8.

Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.

Littauer EQ, Mills LK, Brock N, Esser ES, Romanyuk A, Pulit-Penaloza JA, Vassilieva EV, Beaver JT, Antao O, Krammer F, Compans RW, Prausnitz MR, Skountzou I.

J Control Release. 2018 Apr 28;276:1-16. doi: 10.1016/j.jconrel.2018.02.033. Epub 2018 Feb 26.

9.

Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017.

Belser JA, Brock N, Sun X, Jones J, Zanders N, Hodges E, Pulit-Penaloza JA, Wentworth D, Tumpey TM, Davis T, Maines TR.

Emerg Infect Dis. 2018 Jan;24(1):149-152. doi: 10.3201/eid2401.171574.

10.

Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.

Pulit-Penaloza JA, Simpson N, Yang H, Creager HM, Jones J, Carney P, Belser JA, Yang G, Chang J, Zeng H, Thor S, Jang Y, Killian ML, Jenkins-Moore M, Janas-Martindale A, Dubovi E, Wentworth DE, Stevens J, Tumpey TM, Davis CT, Maines TR.

J Infect Dis. 2017 Sep 15;216(suppl_4):S499-S507. doi: 10.1093/infdis/jiw620.

11.

Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.

Belser JA, Johnson A, Pulit-Penaloza JA, Pappas C, Pearce MB, Tzeng WP, Hossain MJ, Ridenour C, Wang L, Chen LM, Wentworth DE, Katz JM, Maines TR, Tumpey TM.

Virology. 2017 Nov;511:135-141. doi: 10.1016/j.virol.2017.08.024. Epub 2017 Aug 29.

12.

Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.

Esser ES, Pulit-Penaloza JA, Kalluri H, McAllister D, Vassilieva EV, Littauer EQ, Lelutiu N, Prausnitz MR, Compans RW, Skountzou I.

Sci Rep. 2017 Jul 18;7(1):5705. doi: 10.1038/s41598-017-05940-7.

13.

Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.

Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM.

Virology. 2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26.

14.

A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model.

Belser JA, Pulit-Penaloza JA, Sun X, Brock N, Pappas C, Creager HM, Zeng H, Tumpey TM, Maines TR.

J Virol. 2017 Jul 12;91(15). pii: e00672-17. doi: 10.1128/JVI.00672-17. Print 2017 Aug 1.

15.

In vitro exposure system for study of aerosolized influenza virus.

Creager HM, Zeng H, Pulit-Penaloza JA, Maines TR, Tumpey TM, Belser JA.

Virology. 2017 Jan;500:62-70. doi: 10.1016/j.virol.2016.10.007. Epub 2016 Oct 20.

16.

Pathogenesis and Transmission Assessments of Two H7N8 Influenza A Viruses Recently Isolated from Turkey Farms in Indiana Using Mouse and Ferret Models.

Sun X, Belser JA, Pulit-Penaloza JA, Zeng H, Lewis A, Shieh WJ, Tumpey TM, Maines TR.

J Virol. 2016 Nov 14;90(23):10936-10944. doi: 10.1128/JVI.01646-16. Print 2016 Dec 1.

17.

Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.

Pushko P, Sun X, Tretyakova I, Hidajat R, Pulit-Penaloza JA, Belser JA, Maines TR, Tumpey TM.

Vaccine. 2016 Oct 17;34(44):5235-5242. doi: 10.1016/j.vaccine.2016.09.012. Epub 2016 Sep 20.

18.

Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

Pulit-Penaloza JA, Sapkota B, Stein Esser E, Compans RW, Pollack BP, Skountzou I.

Sci Rep. 2015 Jul 31;5:12321. doi: 10.1038/srep12321.

19.

Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and Mice.

Pulit-Penaloza JA, Sun X, Creager HM, Zeng H, Belser JA, Maines TR, Tumpey TM.

J Virol. 2015 Oct;89(20):10286-93. doi: 10.1128/JVI.01438-15. Epub 2015 Jul 29.

20.

Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.

Vassilieva EV, Kalluri H, McAllister D, Taherbhai MT, Esser ES, Pewin WP, Pulit-Penaloza JA, Prausnitz MR, Compans RW, Skountzou I.

Drug Deliv Transl Res. 2015 Aug;5(4):360-71. doi: 10.1007/s13346-015-0228-0.

21.

A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches.

Pulit-Penaloza JA, Esser ES, Vassilieva EV, Lee JW, Taherbhai MT, Pollack BP, Prausnitz MR, Compans RW, Skountzou I.

Sci Rep. 2014 Aug 18;4:6094. doi: 10.1038/srep06094.

22.
23.

Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Pulit-Penaloza JA, Scherbik SV, Brinton MA.

Virology. 2012 Apr 10;425(2):82-94. doi: 10.1016/j.virol.2012.01.006. Epub 2012 Feb 3.

24.

Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation.

Pulit-Penaloza JA, Scherbik SV, Brinton MA.

Virology. 2012 Apr 10;425(2):71-81. doi: 10.1016/j.virol.2011.11.025. Epub 2012 Feb 3.

Supplemental Content

Loading ...
Support Center